Table 2.
Clinical data according to hepatocellular adenoma subtypes. (The patient with both H-HCA and IHCA is not included in the table.)
| Characteristics | H-HCA | IHCA | b-HCA | Unclassified |
|---|---|---|---|---|
| Number of cases | 9 (25 %) | 20 (55.5%) | 5 (14%) | 2 (5.5%) |
| Age (years) | 27–68 | 17–49 | 11–42 | 28, 32 |
| BMI (kg/m2) | ||||
| <25 | 6 | 8 | 4 | 0 |
| ≥25 | 3 (28%) | 9 (45%) | 1 (20%) | 2 (100%) |
| Unknown | 0 | 3 | 0 | 0 |
| Sex | ||||
| Females | 9 | 18 | 3 | 2 |
| Males | 0 | 2 | 2 | 0 |
| Number of HCA (radiological) | ||||
| Single | 4 (44.4%) | 12 (60%) | 5 (100%) | 1 (50%) |
| Multiple | 5 (1 adenomatosis) | 8 (2 adenomatosis) | 0 | 1 |
| Symptoms | ||||
| Bleeding | 4 (44.4%) | 7 (35%) | 1 (20%) | 2 (100%) |
| Aspecific/incidental finding | 5 | 11 | 4 | 0 |
| Unknown | 2 | |||
| OC use (32 women) | ||||
| Yes | 5 (55.5%) | 10 (50%) | 2 (67%) | 2 (100%) |
| No | 3 | 6 | 1 | |
| Unknown | 1 | 2 | ||
| Size of lesions (mm) | 30–100 | 27–140 | 50–180 | 66–100 |
| Followup (range in months) | 10–129 | 10–200 | 8–120 | 24–83 |
| Alive without recurrence | 6 | 16 | 5 | 2 |
| Alive with recurrence | ||||
| Alive with residual HCA | 1 | 2 | ||
| Unknown | 2 | 2 |